Literature DB >> 3042204

Reliability of lipid, lipoprotein, and apolipoprotein measurements.

H K Naito1.   

Abstract

The National Heart, Lung, and Blood Institute national awareness program on cholesterol and heart disease has placed new demands on laboratorians to utilize and perform more reliable measurements of lipids, lipoproteins, and apolipoproteins. The general public's awareness and the clinicians' concerns about the reliability of laboratory testing make it paramount that the analytical problems and issues are identified and solutions are provided to increase the current state of reliability of the measurement of these blood constituents. To accomplish this, the initial step is to assess the current state of reliability of lipid, lipoprotein, and apolipoprotein measurements in the clinical laboratories. Accuracy and precision of measurements of total cholesterol, triglycerides, high-density lipoprotein cholesterol, and apolipoproteins A-I and B are extensively discussed, and general as well as some specific recommendations are provided for some of the apparent problems.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042204

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Early detection and treatment of hyperlipidemia: physician practices in Canada.

Authors:  T N Tannenbaum; J S Sampalis; R N Battista; E R Rosenberg; L Joseph
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

2.  Comparisons of referral criteria for public screening of blood cholesterol levels.

Authors:  R G Wones; K M Kerman; D C Hissa; N Meloy; E A Stein
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

3.  Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research.

Authors:  Zhu Chen; Alison M Strack; Alice C Stefanni; Ying Chen; Weizhen Wu; Yi Pan; Olga Urosevic-Price; Li Wang; Theresa McLaughlin; Neil Geoghagen; Michael E Lassman; Thomas P Roddy; Kenny K Wong; Brian K Hubbard; Amy M Flattery
Journal:  J Cardiovasc Transl Res       Date:  2011-03-11       Impact factor: 4.132

4.  Serum cholesterol concentrations among Navajo Indians.

Authors:  J R Sugarman; T J Gilbert; C A Percy; D G Peter
Journal:  Public Health Rep       Date:  1992 Jan-Feb       Impact factor: 2.792

5.  Argan Oil Exerts an Antiatherogenic Effect by Improving Lipids and Susceptibility of LDL to Oxidation in Type 2 Diabetes Patients.

Authors:  M M Ould Mohamedou; K Zouirech; M El Messal; M S El Kebbaj; A Chraibi; A Adlouni
Journal:  Int J Endocrinol       Date:  2011-11-01       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.